Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis.
about
Therapeutic Strategies to Treat Dry Eye in an Aging PopulationEffects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease.Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.Review of Azithromycin Ophthalmic 1% Solution (AzaSite(®)) for the Treatment of Ocular Infections.A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin-0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment oClinical Findings, Follow-up and Treatment Results in Patients with Ocular Rosacea.Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite) solution in the treatment of ocular infections.Meibomian Gland Alteration in Patients with Primary Chronic Dacryocystitis: An In vivo Confocal Microscopy Study.Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction.[Treatment options for chronic blepharitis considering current evidence].Preclinical development of MGO Manuka Honey microemulsion for blepharitis management
P2860
Q26822610-BB219078-2FEF-4A3A-A409-A4AD3149757EQ33870384-20A5CBC6-3BAC-4E2C-9D71-C8D95F8F4138Q36252489-1DB1EDED-EB1E-4D4A-B96F-C527E617425EQ36748179-37D1792D-A910-4E8E-AACD-3B589116DCF5Q37179917-9D147902-29FB-4421-9CC4-AE5AC3E75BB7Q37360910-095AFACC-AC19-4AB3-A53C-4C7F9E95821CQ42789151-5BBFD490-091D-4FBE-9CA6-AE68EB94327EQ44344585-EAB83403-31BF-4D4A-9482-EC0EA5536D76Q47278045-17D01BC7-2527-4547-A98E-7022DF4D967FQ53555421-28747BEB-865A-4D10-B275-BEBD040CD36CQ57593858-99EB9AA6-012E-4220-9A07-DD511B69A3A1
P2860
Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Efficacy of azithromycin 1% op ...... se from posterior blepharitis.
@en
Efficacy of azithromycin 1% op ...... se from posterior blepharitis.
@nl
type
label
Efficacy of azithromycin 1% op ...... se from posterior blepharitis.
@en
Efficacy of azithromycin 1% op ...... se from posterior blepharitis.
@nl
prefLabel
Efficacy of azithromycin 1% op ...... se from posterior blepharitis.
@en
Efficacy of azithromycin 1% op ...... se from posterior blepharitis.
@nl
P2860
P1476
Efficacy of azithromycin 1% op ...... se from posterior blepharitis.
@en
P2093
Dominick L Opitz
Keith F Tyler
P2860
P304
P356
10.1111/J.1444-0938.2010.00540.X
P577
2010-11-17T00:00:00Z